50 tl ICIAC 2009 Time to < 1000 copies/mL Oral Sup 150 Placebo Vaixnecclov • 10 15 Days p -0 04 2;1 23 EFTA00506092 EPB-348, transplant, & Epstein-Barr Virus (EBV) Background • EBV-driven diseases such as Post-Transplant Lymphoprotiferative Disorder (PTLD), EBV-encephalitis, and EBV-pneumonitis are imp